Comparison of vital sign stability and cost effectiveness between midazolam and dexmedetomidine during third molar extraction under intravenous sedation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: To compare the vital sign stability and cost of two commonly used sedatives, midazolam (MDZ) and dexmedetomidine (DEX). Patients and Methods: This retrospective study targeted patients who underwent mandibular third molar extractions under intravenous sedation using MDZ or DEX. The predictor variable was the type of sedative used. The primary outcome variables were vital signs (heart rate and blood pres-sure), vital sign outliers, and cost of the sedatives. A vital sign outlier was defined as a 30% or more change in vital signs during sedation; the fewer changes, the higher the vital sign stability. The secondary outcome variables included the observer’s assessment of alertness/sedation scale, level of amnesia, patient satisfaction, and bispectral index score. Covariates were sex, age, body mass index, sleeping time, dental anxiety score, and Pederson scale. Descriptive statistics were computed including propensity score matching (PSM). The P-value was set at 0.05. Results: The study enrolled 185 patients, 103 in the MDZ group and 82 in the DEX group. Based on the data after PSM, the two samples had simi-lar baseline covariates. The sedative effect of both agents was satisfactory. Heart rate outliers were more common with MDZ than with DEX (49.3% vs 22.7%, P=0.001). Heart rate was higher with MDZ (P=0.000). The cost was higher for DEX than for MDZ (29.27±0.00 USD vs 0.37±0.04 USD, P=0.000). Conclusion: DEX showed more vital sign stability, while MDZ was more economical. These results could be used as a reference to guide clinicians during sedative selection.
Abstract
Objectives: To compare the vital sign stability and cost of two commonly used sedatives, midazolam (MDZ) and dexmedetomidine (DEX). Patients and Methods: This retrospective study targeted patients who underwent mandibular third molar extractions under intravenous sedation using MDZ or DEX. The predictor variable was the type of sedative used. The primary outcome variables were vital signs (heart rate and blood pres-sure), vital sign outliers, and cost of the sedatives. A vital sign outlier was defined as a 30% or more change in vital signs during sedation; the fewer changes, the higher the vital sign stability. The secondary outcome variables included the observer’s assessment of alertness/sedation scale, level of amnesia, patient satisfaction, and bispectral index score. Covariates were sex, age, body mass index, sleeping time, dental anxiety score, and Pederson scale. Descriptive statistics were computed including propensity score matching (PSM). The P-value was set at 0.05. Results: The study enrolled 185 patients, 103 in the MDZ group and 82 in the DEX group. Based on the data after PSM, the two samples had simi-lar baseline covariates. The sedative effect of both agents was satisfactory. Heart rate outliers were more common with MDZ than with DEX (49.3% vs 22.7%, P=0.001). Heart rate was higher with MDZ (P=0.000). The cost was higher for DEX than for MDZ (29.27±0.00 USD vs 0.37±0.04 USD, P=0.000). Conclusion: DEX showed more vital sign stability, while MDZ was more economical. These results could be used as a reference to guide clinicians during sedative selection.
참고문헌 (24)
- Zhang Y, "Comparison of dexmedetomidine with midazolam for dental surgery: a systematic review and meta-analysis", Medicine(Baltimore), 99, pp.e22288~ (2020)[DOI]
- Fan TW, "Comparison of dexmedetomidine and midazolam for conscious sedation in dental surgery monitored by bispectral index", Br J Oral Maxillofac Surg, 51, pp.428~433 (2013)[DOI]
- Mika Seto, "Sedation with dexmedetomidine in elderly patients during dental surgery: a retrospective case series", 대한구강악안면외과학회지, 45(3), pp.152~157 (2019), 대한구강악안면외과학회[DOI]
- Prommer E, "Midazolam : an essential palliative care drug", Palliat Care Soc Pract, 14, pp.2632352419895527~ (2020)[DOI]
- Candiotti KA, "Monitored anesthesia care with dexmedetomidine : a prospective, randomized, doubleblind, multicenter trial", Anesth Analg, 110, pp.47~56 (2010)[DOI]
- 신동환, "Risk factor analysis of additional administration of sedative agent and patient dissatisfaction in intravenous conscious sedation using midazolam for third molar extraction", 대한구강악안면외과학회지, 43(4), pp.229~238 (2017), 대한구강악안면외과학회
- "Practice guidelines for moderate procedural sedation and analgesia 2018: a report by the American Society of Anesthesiologists Task Force on Moderate Procedural Sedation and Analgesia, the American Association of Oral and Maxillofacial Surgeons, American College of Radiology, American Dental Association, American Society of Dentist Anesthesiologists, and Society of Interventional Radiology", Anesthesiology, 128(3), pp.437~479 (2018), Ovid Technologies (Wolters Kluwer Health)[DOI]
- de Moares MB, "Comparison of three anxiety management protocols for extraction of third molars with the use of midazolam, diazepam, and nitrous oxide : a randomized clinical trial", J Oral Maxillofac Surg, 77, pp.2258.e1~2258.e8 (2019)[DOI]
- Chernik DA, "Validity and reliability of the Observerʼs Assessment of Alertness", Sedation Scale : study with intravenous midazolam, 1990, pp.10, 244~251
- Corah NL, "Development of a dental anxiety scale", J Dent Res, 48, pp.596~ (1969)[DOI]
- Gbotolorun OM, "Assessment of factors associated with surgical difficulty in impacted mandibular third molar extraction", J Oral Maxillofac Surg, 65, pp.1977~1983 (2007)[DOI]
- Acharya S, "Anxiety level of patients undergoing oral surgical procedures", J Nepal Health Res Counc, 16, pp.27~31 (2018)
- Udoye CI, "Dental anxiety among patients undergoing various dental treatments in a Nigerian teaching hospital", J Contemp Dent Pract, 6, pp.91~98 (2005)
- Appukuttan D, "Reliability and validity of the Tamil version of Modified Dental Anxiety Scale", J Oral Sci, 54, pp.313~320 (2012)[DOI]
- Liu HH, "Effect of a beta-adrenergic blocking agent on dental anxiety", J Dent Res, 70, pp.1306~1308 (1991)[DOI]
- Ogawa S, "Intravenous sedation with low-dose dexmedetomidine : its potential for use in dentistry", Anesth Prog, 55, pp.82~88 (2008)[DOI]
- Shin S, "Heart rate variability dynamics during controlled hypotension with nicardipine, remifentanil and dexmedetomidine", Acta Anaesthesiol Scand, 58, pp.168~176 (2014)[DOI]
- Yu C, "Comparison of dexmedetomidine", fentanyl with midazolam, Int J Oral Maxillofac Surg, pp.2014, 43[DOI]
- Barends CR, "Dexmedetomidine versus midazolam in procedural sedation. A systematic review of efficacy and safety", PLoS One, 12, pp.e0169525~ (2017)[DOI]
- Parikh DA, "A prospective randomized double-blind study comparing dexmedetomidine vs. combination of midazolam-fentanyl for tympanoplasty surgery under monitored anesthesia care", J Anaesthesiol Clin Pharmacol, 29, pp.173~178 (2013)[DOI]
- Silva-Jr JM, "Comparison of dexmedetomidine and benzodiazepine for intraoperative sedation in elderly patients : a randomized clinical trial", Reg Anesth Pain Med, 44, pp.319~324 (2019)[DOI]
- Lachaine J, "Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit", Can J Hosp Pharm, 65, pp.103~110 (2012)[DOI]
- Aggarwal J, "Cost-minimization analysis of dexmedetomidine compared to other sedatives for short-term sedation during mechanical ventilation in the United States", Clinicoecon Outcomes Res, 12, pp.389~397 (2020)
- Wang L, "Comparison in sedative effects between dexmedetomidine and midazolam in dental implantation : a randomized clinical trial", Biomed Res Int, 2020, pp.6130162~ (2020)[DOI]